메뉴 건너뛰기




Volumn 131, Issue 1, 2012, Pages 18-29

Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo

Author keywords

decitabine; differentiation; DNA methyl transferase 1; DNMT1; melanoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE 1; PROTEIN P53; TRANSCRIPTION FACTOR SOX9;

EID: 84856377986     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26320     Document Type: Article
Times cited : (65)

References (50)
  • 1
    • 0018100206 scopus 로고
    • Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma
    • Bellet RE, Catalano RB, Mastrangelo MJ, Berd D,. Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma. Med Pediatr Oncol 1978; 4: 11-5.
    • (1978) Med Pediatr Oncol , vol.4 , pp. 11-15
    • Bellet, R.E.1    Catalano, R.B.2    Mastrangelo, M.J.3    Berd, D.4
  • 2
    • 0027285909 scopus 로고
    • A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma
    • Creagan ET, Schaid DJ, Hartmann LC, Loprinzi CL,. A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma. Am J Clin Oncol 1993; 16: 243-4.
    • (1993) Am J Clin Oncol , vol.16 , pp. 243-244
    • Creagan, E.T.1    Schaid, D.J.2    Hartmann, L.C.3    Loprinzi, C.L.4
  • 3
    • 36549085004 scopus 로고    scopus 로고
    • The genome and epigenome of malignant melanoma
    • Dahl C, Guldberg P,. The genome and epigenome of malignant melanoma. APMIS 2007; 115: 1161-76.
    • (2007) APMIS , vol.115 , pp. 1161-1176
    • Dahl, C.1    Guldberg, P.2
  • 4
    • 0023573963 scopus 로고
    • The EORTC early clinical trials cooperative group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas
    • Abele R, Clavel M, Dodion P, Bruntsch U, Gundersen S, Smyth J, Renard J, van Glabbeke M, Pinedo HM,. The EORTC early clinical trials cooperative group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas. Eur J Cancer Clin Oncol 1987; 23: 1921-4.
    • (1987) Eur J Cancer Clin Oncol , vol.23 , pp. 1921-1924
    • Abele, R.1    Clavel, M.2    Dodion, P.3    Bruntsch, U.4    Gundersen, S.5    Smyth, J.6    Renard, J.7    Van Glabbeke, M.8    Pinedo, H.M.9
  • 6
    • 33748046812 scopus 로고    scopus 로고
    • Phase i trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma
    • Gollob JA, Sciambi CJ, Peterson BL, Richmond T, Thoreson M, Moran K, Dressman HK, Jelinek J, Issa JP,. Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. Clin Cancer Res 2006; 12: 4619-27.
    • (2006) Clin Cancer Res , vol.12 , pp. 4619-4627
    • Gollob, J.A.1    Sciambi, C.J.2    Peterson, B.L.3    Richmond, T.4    Thoreson, M.5    Moran, K.6    Dressman, H.K.7    Jelinek, J.8    Issa, J.P.9
  • 7
    • 12444252093 scopus 로고    scopus 로고
    • Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice
    • Kozar K, Kaminski R, Switaj T, Oldak T, Machaj E, Wysocki PJ, Mackiewicz A, Lasek W, Jakobisiak M, Golab J,. Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice. Clin Cancer Res 2003; 9: 3124-33.
    • (2003) Clin Cancer Res , vol.9 , pp. 3124-3133
    • Kozar, K.1    Kaminski, R.2    Switaj, T.3    Oldak, T.4    MacHaj, E.5    Wysocki, P.J.6    MacKiewicz, A.7    Lasek, W.8    Jakobisiak, M.9    Golab, J.10
  • 12
    • 0029890258 scopus 로고    scopus 로고
    • Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma
    • Triozzi PL, Walker MJ, Pellegrini AE, Dayton MA,. Isotretinoin and recombinant interferon alfa-2a therapy of metastatic malignant melanoma. Cancer Invest 1996; 14: 293-8.
    • (1996) Cancer Invest , vol.14 , pp. 293-298
    • Triozzi, P.L.1    Walker, M.J.2    Pellegrini, A.E.3    Dayton, M.A.4
  • 13
    • 0023719531 scopus 로고
    • Variable DNA methylation changes during differentiation of human melanoma cells
    • Steigerwald SD, Pfeifer GP,. Variable DNA methylation changes during differentiation of human melanoma cells. Exp Cell Res 1988; 178: 41-50.
    • (1988) Exp Cell Res , vol.178 , pp. 41-50
    • Steigerwald, S.D.1    Pfeifer, G.P.2
  • 15
    • 65249112671 scopus 로고    scopus 로고
    • Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid
    • Passeron T, Valencia JC, Namiki T, Vieira WD, Passeron H, Miyamura Y, Hearing VJ,. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid. J Clin Invest 2009; 119: 954-63.
    • (2009) J Clin Invest , vol.119 , pp. 954-963
    • Passeron, T.1    Valencia, J.C.2    Namiki, T.3    Vieira, W.D.4    Passeron, H.5    Miyamura, Y.6    Hearing, V.J.7
  • 16
    • 77949389035 scopus 로고    scopus 로고
    • Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells
    • Sestakova B, Ondrusova L, Vachtenheim J,. Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells. Pigment Cell Melanoma Res 2010; 23: 238-51.
    • (2010) Pigment Cell Melanoma Res , vol.23 , pp. 238-251
    • Sestakova, B.1    Ondrusova, L.2    Vachtenheim, J.3
  • 17
    • 0033572879 scopus 로고    scopus 로고
    • Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes
    • Haddad MM, Xu W, Schwahn DJ, Liao F, Medrano EE,. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Exp Cell Res 1999; 253: 561-72.
    • (1999) Exp Cell Res , vol.253 , pp. 561-572
    • Haddad, M.M.1    Xu, W.2    Schwahn, D.J.3    Liao, F.4    Medrano, E.E.5
  • 18
    • 33645521995 scopus 로고    scopus 로고
    • Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification method
    • Liu Z, Marcucci G, Byrd JC, Grever M, Xiao J, Chan KK,. Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification method. Rapid Commun Mass Spectrom 2006; 20: 1117-26.
    • (2006) Rapid Commun Mass Spectrom , vol.20 , pp. 1117-1126
    • Liu, Z.1    Marcucci, G.2    Byrd, J.C.3    Grever, M.4    Xiao, J.5    Chan, K.K.6
  • 19
    • 60249094793 scopus 로고    scopus 로고
    • Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines
    • Qin T, Jelinek J, Si J, Shu J, Issa JP,. Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines. Blood 2009; 113: 659-67.
    • (2009) Blood , vol.113 , pp. 659-667
    • Qin, T.1    Jelinek, J.2    Si, J.3    Shu, J.4    Issa, J.P.5
  • 22
    • 10744231450 scopus 로고    scopus 로고
    • Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
    • Saunthararajah Y, Hillery CA, Lavelle D, Molokie R, Dorn L, Bressler L, Gavazova S, Chen YH, Hoffman R, DeSimone J,. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease. Blood 2003; 102: 3865-70.
    • (2003) Blood , vol.102 , pp. 3865-3870
    • Saunthararajah, Y.1    Hillery, C.A.2    Lavelle, D.3    Molokie, R.4    Dorn, L.5    Bressler, L.6    Gavazova, S.7    Chen, Y.H.8    Hoffman, R.9    Desimone, J.10
  • 24
    • 77951743776 scopus 로고    scopus 로고
    • Expression of Sox-9 in metastatic melanoma-a potential diagnostic pitfall
    • Rao P, Fuller GN, Prieto VG,. Expression of Sox-9 in metastatic melanoma-a potential diagnostic pitfall. Am J Dermatopathol 2010; 32: 262-6.
    • (2010) Am J Dermatopathol , vol.32 , pp. 262-266
    • Rao, P.1    Fuller, G.N.2    Prieto, V.G.3
  • 26
    • 61849134892 scopus 로고    scopus 로고
    • Mechanisms for reaching the differentiated state: Insights from neural crest-derived melanocytes
    • Cooper CD, Raible DW,. Mechanisms for reaching the differentiated state: insights from neural crest-derived melanocytes. Semin Cell Dev Biol 2009; 20: 105-10.
    • (2009) Semin Cell Dev Biol , vol.20 , pp. 105-110
    • Cooper, C.D.1    Raible, D.W.2
  • 27
    • 67349171584 scopus 로고    scopus 로고
    • Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy
    • Sherbet GV,. Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 2009; 280: 15-30.
    • (2009) Cancer Lett , vol.280 , pp. 15-30
    • Sherbet, G.V.1
  • 29
    • 0016696005 scopus 로고
    • Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice
    • Neil GL, Moxley TE, Kuentzel SL, Manak RC, Hanka LJ,. Enhancement by tetrahydrouridine (NSC-112907) of the oral activity of 5-azacytidine (NSC-102816) in L1210 leukemic mice. Cancer Chemother Rep 1975; 59: 459-65.
    • (1975) Cancer Chemother Rep , vol.59 , pp. 459-465
    • Neil, G.L.1    Moxley, T.E.2    Kuentzel, S.L.3    Manak, R.C.4    Hanka, L.J.5
  • 30
    • 34548844746 scopus 로고    scopus 로고
    • Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells
    • Gollob JA, Sciambi CJ,. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells. Clin Cancer Res 2007; 13: 5219-25.
    • (2007) Clin Cancer Res , vol.13 , pp. 5219-5225
    • Gollob, J.A.1    Sciambi, C.J.2
  • 31
    • 38349041706 scopus 로고    scopus 로고
    • Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL
    • Bae SI, Cheriyath V, Jacobs BS, Reu FJ, Borden EC,. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Oncogene 2008; 27: 490-8.
    • (2008) Oncogene , vol.27 , pp. 490-498
    • Bae, S.I.1    Cheriyath, V.2    Jacobs, B.S.3    Reu, F.J.4    Borden, E.C.5
  • 35
    • 0018860957 scopus 로고
    • Cellular differentiation, cytidine analogs and DNA methylation
    • Jones PA, Taylor SM,. Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20: 85-93.
    • (1980) Cell , vol.20 , pp. 85-93
    • Jones, P.A.1    Taylor, S.M.2
  • 36
    • 68049148642 scopus 로고    scopus 로고
    • Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens
    • Cruz-Munoz W, Man S, Kerbel RS,. Effective treatment of advanced human melanoma metastasis in immunodeficient mice using combination metronomic chemotherapy regimens. Clin Cancer Res 2009; 15: 4867-74.
    • (2009) Clin Cancer Res , vol.15 , pp. 4867-4874
    • Cruz-Munoz, W.1    Man, S.2    Kerbel, R.S.3
  • 37
    • 0344010691 scopus 로고    scopus 로고
    • Cancer robustness: Tumour tactics
    • Kitano H,. Cancer robustness: tumour tactics. Nature 2003; 426: 125.
    • (2003) Nature , vol.426 , pp. 125
    • Kitano, H.1
  • 38
    • 0027449966 scopus 로고
    • Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin
    • Marsh JH, Kreis W, Barile B, Akerman S, Schulman P, Allen SL, DeMarco LC, Schuster MW, Budman DR,. Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin. Cancer Chemother Pharmacol 1993; 31: 481-4.
    • (1993) Cancer Chemother Pharmacol , vol.31 , pp. 481-484
    • Marsh, J.H.1    Kreis, W.2    Barile, B.3    Akerman, S.4    Schulman, P.5    Allen, S.L.6    Demarco, L.C.7    Schuster, M.W.8    Budman, D.R.9
  • 39
    • 22144462047 scopus 로고    scopus 로고
    • Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro
    • Cook AL, Smith AG, Smit DJ, Leonard JH, Sturm RA,. Co-expression of SOX9 and SOX10 during melanocytic differentiation in vitro. Exp Cell Res 2005; 308: 222-35.
    • (2005) Exp Cell Res , vol.308 , pp. 222-235
    • Cook, A.L.1    Smith, A.G.2    Smit, D.J.3    Leonard, J.H.4    Sturm, R.A.5
  • 40
    • 0031440272 scopus 로고    scopus 로고
    • Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development
    • Chellappan SP, Giordano A, Fisher PB,. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development. Curr Top Microbiol Immunol 1998; 227: 57-103.
    • (1998) Curr Top Microbiol Immunol , vol.227 , pp. 57-103
    • Chellappan, S.P.1    Giordano, A.2    Fisher, P.B.3
  • 41
    • 0031851739 scopus 로고    scopus 로고
    • Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: Inverse correlation with disease-free survival
    • Florenes VA, Maelandsmo GM, Kerbel RS, Slingerland JM, Nesland JM, Holm R,. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival. Am J Pathol 1998; 153: 305-12.
    • (1998) Am J Pathol , vol.153 , pp. 305-312
    • Florenes, V.A.1    Maelandsmo, G.M.2    Kerbel, R.S.3    Slingerland, J.M.4    Nesland, J.M.5    Holm, R.6
  • 43
    • 0037133695 scopus 로고    scopus 로고
    • Glial protein S100B modulates long-term neuronal synaptic plasticity
    • Nishiyama H, Knopfel T, Endo S, Itohara S,. Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc Natl Acad Sci USA 2002; 99: 4037-42.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 4037-4042
    • Nishiyama, H.1    Knopfel, T.2    Endo, S.3    Itohara, S.4
  • 44
    • 0036993573 scopus 로고    scopus 로고
    • Melanoma development and progression: A conspiracy between tumor and host
    • Hsu MY, Meier F, Herlyn M,. Melanoma development and progression: a conspiracy between tumor and host. Differentiation 2002; 70: 522-36.
    • (2002) Differentiation , vol.70 , pp. 522-536
    • Hsu, M.Y.1    Meier, F.2    Herlyn, M.3
  • 46
    • 29344459785 scopus 로고    scopus 로고
    • Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma
    • Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA,. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11: 8606-14.
    • (2005) Clin Cancer Res , vol.11 , pp. 8606-8614
    • Bachmann, I.M.1    Straume, O.2    Puntervoll, H.E.3    Kalvenes, M.B.4    Akslen, L.A.5
  • 48
    • 0035957015 scopus 로고    scopus 로고
    • Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells
    • Mishra N, Brown DR, Olorenshaw IM, Kammer GM,. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. Proc Natl Acad Sci USA 2001; 98: 2628-33.
    • (2001) Proc Natl Acad Sci USA , vol.98 , pp. 2628-2633
    • Mishra, N.1    Brown, D.R.2    Olorenshaw, I.M.3    Kammer, G.M.4
  • 49
    • 77956568079 scopus 로고    scopus 로고
    • Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens
    • Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der BP, Coulie P, De Plaen E,. Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens. Int J Cancer. 2010; 127: 1625-36.
    • (2010) Int J Cancer. , vol.127 , pp. 1625-1636
    • Kholmanskikh, O.1    Van Baren, N.2    Brasseur, F.3    Ottaviani, S.4    Vanacker, J.5    Arts, N.6    Van Der, B.P.7    Coulie, P.8    De Plaen, E.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.